{"celex_id": "32013D0629(02)", "uri": "http://publications.europa.eu/resource/cellar/7fbf5aac-e092-11e2-9165-01aa75ed71a1", "type": "Decision", "concepts": ["3813", "4455", "5426", "5451", "5734", "5916"], "title": "Commission Decision of 28\u00a0June 2013 appointing members and alternates of the Committee for Advanced Therapies to represent clinicians and patients' associations  Text with EEA relevance\n", "header": "29.6.2013 EN Official Journal of the European Union C 187/9\nCOMMISSION DECISION\nof 28 June 2013\nappointing members and alternates of the Committee for Advanced Therapies to represent clinicians and patients' associations\n(Text with EEA relevance)\n2013/C 187/08\nTHE EUROPEAN COMMISSION", "recitals": ",\nHaving regard to the Treaty on the Functioning of the European Union,\nHaving regard to Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency\u00a0(1), and in particular Article 21(1) thereof,\nWhereas:\n(1) Regulation (EC) No 1394/2007 lays down specific rules concerning the authorisation, supervision and pharmacovigilance of advanced therapy medicinal products. Article 20 of that Regulation lays down that a Committee for Advanced Therapies shall be established within the European Medicines Agency.\n(2) Subparagraph (c) of Article 21(1) of Regulation (EC) No 1394/2007 lays down that the Committee for Advanced Therapies shall include two members and two alternates appointed by the Commission, on the basis of a public call for expressions of interest and after consulting the European Parliament, in order to represent clinicians.\n(3) Subparagraph (d) of Article 21(1) of Regulation (EC) No 1394/2007 lays down that the Committee for Advanced Therapies shall include two members and two alternates appointed by the Commission, on the basis of a public call for expressions of interest and after consulting the European Parliament, in order to represent patients' associations.\n(4) In accordance with Article 21(3) of Regulation (EC) No 1394/2007, the members and alternates of the Committee for Advanced Therapies are appointed for a period of 3 years. The term of office of the members and alternates appointed in 2009 has expired and therefore a new call has been undertaken in 2012.\n(5) In accordance with Article 21(1) of Regulation (EC) No 1394/2007, a public call for expression of interest has been undertaken by the Commission. The European Parliament has been consulted on the results of the evaluation of the applications received,", "main_body": ["The following are hereby appointed members and alternates of the Committee for Advanced Therapies to represent clinicians for a term of 3 years, from 1 July 2013:\n\u2014 Pieter DOEVENDANS (Member) and Esteve TRIAS (Alternate),\n\u2014 Bernd G\u00c4NSBACHER (Member) and Ramadan JASHARI (Alternate).", "The following are hereby appointed members and alternates of the Committee for Advanced Therapies to represent patients' associations for a term of 3 years, from 1 July 2013:\n\u2014 Michele LIPUCCI DI PAOLA (Member) and Monica ENSINI (Alternate),\n\u2014 Kieran BREEN (Member) and Mariette DRIESSENS (Alternate)."], "attachments": "Done at Brussels, 28 June 2013.\nFor the Commission\nTonio BORG\nMember of the Commission\n(1)\u00a0\u00a0OJ L 136, 30.4.2004, p. 1."}